IL-22BP is produced by eosinophils in human gut and blocks IL-22 protective actions during colitis

J C Martin; G Bériou; M Heslan; C Bossard; A Jarry; A Abidi; P Hulin; S Ménoret; R Thinard; I Anegon; C Jacqueline; B Lardeux; F Halary; J-C Renauld; A Bourreille; R Josien

doi:10.1038/mi.2015.83

journal article Open Access Mar 01, 2016

IL-22BP is produced by eosinophils in human gut and blocks IL-22 protective actions during colitis

J C Martin G Bériou M Heslan C Bossard A Jarry A Abidi P Hulin S Ménoret R Thinard I Anegon C Jacqueline B Lardeux F Halary J-C Renauld A Bourreille R Josien

Mucosal Immunology Vol. 9 No. 2 pp. 539-549 · Elsevier BV

View at Publisher Save 10.1038/mi.2015.83

Topics

No keywords indexed for this article. Browse by subject →

References

49

[1]

Kaser "Inflammatory bowel disease" Annu. Rev. Immunol. (2010) 10.1146/annurev-immunol-030409-101225

[2]

Sabat "Therapeutic opportunities of the IL-22-IL-22R1 system" Nat. Rev. Drug. Discov. (2013) 10.1038/nrd4176

[3]

Andoh "Interleukin-22, a member of the IL-10 subfamily, induces inflammatory responses in colonic subepithelial myofibroblasts" Gastroenterology (2005) 10.1053/j.gastro.2005.06.071

[4]

Brand "IL-22 is increased in active Crohn's disease and promotes proinflammatory gene expression and intestinal epithelial cell migration" Am. J. Physiol. Gastrointest. Liver Physiol. (2006) 10.1152/ajpgi.00513.2005

[5]

Schmechel "Linking genetic susceptibility to Crohn's disease with Th17 cell function: IL-22 serum levels are increased in Crohn's disease and correlate with disease activity and IL23R genotype status" Inflamm. Bowel. Dis. (2008) 10.1002/ibd.20315

[6]

Sugimoto "IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis" J Clin Invest (2008)

[7]

Pariente "Activation of the receptor NKG2D leads to production of Th17 cytokines in CD4+ T cells of patients with Crohn's disease" Gastroenterology (2011) 10.1053/j.gastro.2011.03.061

[8]

Geremia "IL-23-responsive innate lymphoid cells are increased in inflammatory bowel disease" J. Exp. Med. (2011) 10.1084/jem.20101712

[9]

Innate and Adaptive Interleukin-22 Protects Mice from Inflammatory Bowel Disease

Lauren A. Zenewicz, George D. Yancopoulos, David M. Valenzuela et al.

Immunity 2008 10.1016/j.immuni.2008.11.003

[10]

Pickert "STAT3 links IL-22 signaling in intestinal epithelial cells to mucosal wound healing" J. Exp. Med. (2009) 10.1084/jem.20082683

[11]

Aryl Hydrocarbon Receptor-Induced Signals Up-regulate IL-22 Production and Inhibit Inflammation in the Gastrointestinal Tract

Ivan Monteleone, Angelamaria Rizzo, Massimiliano Sarra et al.

Gastroenterology 2011 10.1053/j.gastro.2011.04.007

[12]

Zindl "IL-22-producing neutrophils contribute to antimicrobial defense and restitution of colonic epithelial integrity during colitis" Proc. Natl Acad. Sci. USA (2013) 10.1073/pnas.1300318110

[13]

Mielke "Retinoic acid expression associates with enhanced IL-22 production by γδ T cells and innate lymphoid cells and attenuation of intestinal inflammation" J. Exp. Med. (2013) 10.1084/jem.20121588

[14]

Xu "A soluble class II cytokine receptor, IL-22RA2, is a naturally occurring IL-22 antagonist" Proc. Natl Acad. Sci. USA (2001) 10.1073/pnas.171303198

[15]

Logsdon "Comparison of interleukin-22 and interleukin-10 soluble receptor complexes" J. Interferon Cytokine Res. (2002) 10.1089/10799900260442520

[16]

Huber "IL-22BP is regulated by the inflammasome and modulates tumorigenesis in the intestine" Nature (2012) 10.1038/nature11535

[17]

Martin "Interleukin-22 binding protein (IL-22BP) is constitutively expressed by a subset of conventional dendritic cells and is strongly induced by retinoic acid" Mucosal Immunol. (2014) 10.1038/mi.2013.28

[18]

Watchmaker "Comparative transcriptional and functional profiling defines conserved programs of intestinal DC differentiation in humans and mice" Nat. Immunol. (2014) 10.1038/ni.2768

[19]

Jung "Roles and regulation of gastrointestinal eosinophils in immunity and disease" J. Immunol. (2014) 10.4049/jimmunol.1400413

[20]

Dumoutier "Cloning and characterization of IL-22 binding protein, a natural antagonist of IL-10-related T cell-derived inducible factor/IL-22" J. Immunol. (2001) 10.4049/jimmunol.166.12.7090

[21]

Hogan "Eosinophils in infection and intestinal immunity" Curr. Opin. Gastroenterol. (2013) 10.1097/mog.0b013e32835ab29a

[22]

Gaudio "Dextran sulfate sodium (DSS) colitis in rats: clinical, structural, and ultrastructural aspects" Dig. Dis Sci. (1999) 10.1023/a:1026620322859

[23]

Zenewicz "IL-22 deficiency alters colonic microbiota to be transmissible and colitogenic" J. Immunol. (2013) 10.4049/jimmunol.1300016

[24]

Sonnenberg "Innate lymphoid cells promote anatomical containment of lymphoid-resident commensal bacteria" Science (2012) 10.1126/science.1222551

[25]

Kleinschek "Circulating and gut-resident human Th17 cells express CD161 and promote intestinal inflammation" J. Exp. Med. (2009) 10.1084/jem.20081712

[26]

Ramesh "Pro-inflammatory human Th17 cells selectively express P-glycoprotein and are refractory to glucocorticoids" J. Exp. Med. (2014) 10.1084/jem.20130301

[27]

Longman "CX3CR1+ mononuclear phagocytes support colitis-associated innate lymphoid cell production of IL-22" J. Exp. Med. (2014) 10.1084/jem.20140678

[28]

Kamada "Unique CD14 intestinal macrophages contribute to the pathogenesis of Crohn disease via IL-23/IFN-gamma axis" J. Clin. Invest. (2008)

[29]

Begue "Defective IL10 signaling defining a subgroup of patients with inflammatory bowel disease" Am. J. Gastroenterol. (2011) 10.1038/ajg.2011.112

[30]

Nakajima "Gene expression screening of human mast cells and eosinophils using high-density oligonucleotide probe arrays: abundant expression of major basic protein in mast cells" Blood (2001) 10.1182/blood.v98.4.1127

[31]

Macpherson "Standardised animal models of host microbial mutualism" Mucosal Immunol. (2014) 10.1038/mi.2014.113

[32]

Induction of Intestinal Th17 Cells by Segmented Filamentous Bacteria

Ivaylo I. Ivanov, Koji Atarashi, Nicolas Manel et al.

Cell 2009 10.1016/j.cell.2009.09.033

[33]

The Key Role of Segmented Filamentous Bacteria in the Coordinated Maturation of Gut Helper T Cell Responses

Valérie Gaboriau-Routhiau, Sabine Rakotobe, Emelyne Lécuyer et al.

Immunity 2009 10.1016/j.immuni.2009.08.020

[34]

Spencer "Adaptation of innate lymphoid cells to a micronutrient deficiency promotes type 2 barrier immunity" Science (2014) 10.1126/science.1247606

[35]

Ueki "Retinoic acids up-regulate functional eosinophil-driving receptor CCR3" Allergy (2013) 10.1111/all.12175

[36]

Lee "Human versus mouse eosinophils: ‘that which we call an eosinophil, by any other name would stain as red‘" J. Allergy Clin. Immunol. (2012) 10.1016/j.jaci.2012.07.025

[37]

Chu "Eosinophils promote generation and maintenance of immunoglobulin-A-expressing plasma cells and contribute to gut immune homeostasis" Immunity (2014) 10.1016/j.immuni.2014.02.014

[38]

Goto "Segmented filamentous bacteria antigens presented by intestinal dendritic cells drive mucosal Th17 cell differentiation" Immunity (2014) 10.1016/j.immuni.2014.03.005

[39]

Kamada "Role of the gut microbiota in immunity and inflammatory disease" Nat. Rev. Immunol. (2013) 10.1038/nri3430

[40]

Kryczek "IL-22(+)CD4(+) T cells promote colorectal cancer stemness via STAT3 transcription factor activation and induction of the methyltransferase DOT1L" Immunity (2014) 10.1016/j.immuni.2014.03.010

[41]

Memory/effector (CD45RBlo) CD4 T cells are controlled directly by IL-10 and cause IL-22–dependent intestinal pathology

Masahito Kamanaka, Samuel Huber, Lauren A. Zenewicz et al.

Journal of Experimental Medicine 2011 10.1084/jem.20102149

[42]

Eken "IL-23R+ innate lymphoid cells induce colitis via interleukin-22-dependent mechanism" Mucosal Immunol. (2014) 10.1038/mi.2013.33

[43]

Vonarbourg "Regulated expression of nuclear receptor RORγt confers distinct functional fates to NK cell receptor-expressing RORγt(+) innate lymphocytes" Immunity (2010) 10.1016/j.immuni.2010.10.017

[44]

Zheng "Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens" Nat. Med. (2008) 10.1038/nm1720

[45]

The Necroptosis Adaptor RIPK3 Promotes Injury-Induced Cytokine Expression and Tissue Repair

Kenta Moriwaki, Sakthi Balaji, Thomas McQuade et al.

Immunity 2014 10.1016/j.immuni.2014.09.016

[46]

Tryptophan Catabolites from Microbiota Engage Aryl Hydrocarbon Receptor and Balance Mucosal Reactivity via Interleukin-22

Teresa Zelante, Rossana G. Iannitti, Cristina Cunha et al.

Immunity 2013 10.1016/j.immuni.2013.08.003

[47]

Geurts "Knockout rats via embryo microinjection of zinc-finger nucleases" Science (2009) 10.1126/science.1172447

[48]

Maxwell, J.R., Brown, W.A., Smith, C.L., Byrne, F.R. & Viney, J.L. Methods of inducing inflammatory bowel disease in mice. Curr. Protoc. Pharmacol.Chapter 5, Unit 5.58 (2009). 10.1002/0471141755.ph0558s47

[49]

Jarry "Mucosal IL-10 and TGF-beta play crucial roles in preventing LPS-driven, IFN-gamma-mediated epithelial damage in human colon explants" J. Clin. Invest. (2008)

Cited By

82

IL-22BP Modulates Injury in Acute Pancreatitis but Delays Tissue Recovery in Chronic Pancreatitis

Lei Sun, Andrew G. Spiteri · 2025

Cellular and Molecular Gastroentero...

Deficiency of IL-22–binding protein enhances the ability of the gut microbiota to protect against enteric pathogens

José L. Fachi, Blanda Di Luccia · 2024

Proceedings of the National Academy...

Role of Interleukin-22 in ulcerative colitis

Nan Zhao, Chuanguo Liu · 2023

Biomedicine & Pharmacotherapy

IL-22 Binding Protein (IL-22BP) in the Regulation of IL-22 Biology

Lauren A. Zenewicz · 2021

Frontiers in Immunology

Metrics

82

Citations

49

References

Details

Published: Mar 01, 2016
Vol/Issue: 9(2)
Pages: 539-549
License: View

Authors

J

J C Martin

Chemistry Department, Hall-Atwater Laboratories, Wesleyan University, Middletown, CT 06457.

aCentre de Recherche en Nutrition Humaine, INSERM U539, CHU, Hôtel Dieu, and INRA, 44035 Nantes, France, bINSERM U 463, 9 quai Moncousu, 44035 Nantes, France, cImmunology Department, Instituto de Investigaciones Biomedicas, UNAM, Mexico DF, 04510, Mexico

R

R Josien

Cite This Article

J C Martin, G Bériou, M Heslan, et al. (2016). IL-22BP is produced by eosinophils in human gut and blocks IL-22 protective actions during colitis. Mucosal Immunology, 9(2), 539-549. https://doi.org/10.1038/mi.2015.83

IL-22BP is produced by eosinophils in human gut and blocks IL-22 protective actions during colitis

You May Also Like